Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
2.490
-0.260 (-9.45%)
At close: Mar 14, 2025
NGX:NEIMETH Cash Flow Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | 2020 - 2016 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
Net Income | -1,699 | -2,865 | -325.04 | -109.66 | 270.58 | Upgrade
|
Depreciation & Amortization | 130.88 | 126.09 | 115.96 | 119.57 | 107.93 | Upgrade
|
Loss (Gain) From Sale of Assets | -3.6 | -0.97 | - | - | -4.86 | Upgrade
|
Provision & Write-off of Bad Debts | 39.7 | -449.84 | 45.2 | 19.2 | 59.03 | Upgrade
|
Other Operating Activities | 2,796 | 473.65 | 260.84 | 53.07 | 73.22 | Upgrade
|
Change in Accounts Receivable | -802.02 | 997.64 | -137.71 | -6.92 | -309.15 | Upgrade
|
Change in Inventory | 29.15 | -346.13 | -203.78 | -267.21 | -25.27 | Upgrade
|
Change in Accounts Payable | 1,829 | 1,304 | 378.1 | 213.8 | 79.86 | Upgrade
|
Change in Other Net Operating Assets | -35.21 | -12.03 | -1.02 | -83.61 | 23.16 | Upgrade
|
Operating Cash Flow | 2,285 | -773.41 | 132.55 | -61.76 | 346.03 | Upgrade
|
Operating Cash Flow Growth | - | - | - | - | 14.38% | Upgrade
|
Capital Expenditures | -702.92 | -936.14 | -1,270 | -1,143 | -344.07 | Upgrade
|
Sale of Property, Plant & Equipment | 3.6 | 2.25 | - | - | 4.86 | Upgrade
|
Investing Cash Flow | -699.32 | -933.89 | -1,270 | -1,143 | -339.21 | Upgrade
|
Short-Term Debt Issued | - | - | - | 913.16 | - | Upgrade
|
Long-Term Debt Issued | - | 40.64 | - | - | - | Upgrade
|
Total Debt Issued | - | 40.64 | 2,243 | 913.16 | - | Upgrade
|
Long-Term Debt Repaid | -50 | -214.58 | - | -537.12 | -334.28 | Upgrade
|
Total Debt Repaid | -50 | -214.58 | -1,888 | -537.12 | -334.28 | Upgrade
|
Net Debt Issued (Repaid) | -50 | -173.95 | 354.58 | 376.04 | -334.28 | Upgrade
|
Issuance of Common Stock | - | 3,710 | - | - | - | Upgrade
|
Common Dividends Paid | - | - | -106.35 | -132.94 | -123.45 | Upgrade
|
Other Financing Activities | -764.29 | -816.02 | -358.37 | -239.52 | -182.33 | Upgrade
|
Financing Cash Flow | -814.29 | 2,721 | -110.15 | 3.58 | -640.06 | Upgrade
|
Foreign Exchange Rate Adjustments | -1,117 | 791.25 | -3.43 | 0 | 10.1 | Upgrade
|
Net Cash Flow | -345.85 | 1,804 | -1,251 | -1,201 | -623.14 | Upgrade
|
Free Cash Flow | 1,582 | -1,710 | -1,137 | -1,205 | 1.96 | Upgrade
|
Free Cash Flow Margin | 35.40% | -77.37% | -38.95% | -44.57% | 0.06% | Upgrade
|
Free Cash Flow Per Share | 0.37 | -0.40 | -0.60 | -0.63 | 0.00 | Upgrade
|
Cash Interest Paid | 761.78 | 667.95 | 300 | 181.77 | 188.22 | Upgrade
|
Cash Income Tax Paid | 12.49 | 125.84 | 53.76 | 31.81 | 81.18 | Upgrade
|
Levered Free Cash Flow | 583.96 | 54.7 | - | -1,309 | -164.78 | Upgrade
|
Unlevered Free Cash Flow | 1,066 | 472.17 | - | -1,195 | -47.15 | Upgrade
|
Change in Net Working Capital | -1,060 | -1,763 | - | 156.54 | 153.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.